| Date | Title | Description |
| 14.05.2024 | Cohere Health Launches Early Trend Signal Intelligence to Predict Utilization Trends Earlier than Claims-based Methods | Leverages intelligent prior authorization to inform policy and financial strategies up to three months earlier
BOSTON, May 14, 2024 /PRNewswire/ -- Cohere Health®, a recognized leader in clinical intelligence and prior authorization automat... |
| 23.04.2024 | Cohere Health and Humana Expand Prior Authorization Partnership, Adding Diagnostic Imaging and Sleep Services | New solutions elevate and expedite patient care with upstream moments of influence
BOSTON and LOUISVILLE, Ky., April 23, 2024 /PRNewswire/ -- Cohere Health, a recognized leader in clinical intelligence and prior authorization automation, an... |
| 22.04.2024 | Value-based care strategy company Lumeris secures $100M | Photo: francescoridolfi.com/Getty Images
Lumeris, a value-based care strategy, technology and operations company, announced it secured $100 million in an equity capital raise led by Deerfield Management.
Endeavor Health joined as a new inve... |
| 23.02.2024 | Reprieve Cardiovascular Revolutionizes Heart Failure Treatment with $42M Funding | Reprieve Cardiovascular, a Milford, MA-based company, secures $42M in Series A funding to advance intelligent fluid management for heart failure patients. Led by Lightstone Ventures and Sante Ventures, the funding will propel Reprieve's mis... |
| 22.02.2024 | Reprieve Cardiovascular Nabs $42M to Expand Intelligent Fluid Management for Heart Failure | What You Should Know:
– Reprieve Cardiovascular, a pioneer in personalized fluid management for acute decompensated heart failure (ADHF) emerges from stealth launching with $42M in Series A financing round.
– The Series A round was co-led b... |
| 25.10.2022 | COTA Secures New Financing to Accelerate Cancer Research and Treatment Innovation | What You Should Know:
COTA Expands Services and Approaches Milestone of 2 Million Cancer Lives
Building on this latest round of financing, COTA is also announcing the expansion of its data platform to cover nearly 2 million cancer patient l... |
| 09.08.2022 | The Oncology Institute announces $110 million strategic investment by Deerfield Management to accelerate its expansion into new markets | CERRITOS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today announced entry into an agreement for the investment of $11... |
| 19.07.2022 | Humanity Health Raises $6M to Advance Health Equity Through Inclusive Leadership | What You Should Know:
– Humanity Health, a New York City-based career acceleration and talent sourcing platform for underrepresented leaders in healthcare and life sciences, has raised $6 million in Series A funding led by Jumpstart Nova wi... |
| 03.02.2022 | ConcertoCare Raises $105M for Value-Based At-Home Care for Seniors | What You Should Know:
– ConcertoCare, a value-based care provider of at-home care for seniors and other adults with unmet health and social needs raises $105M in Series B funding led by Wells Fargo Strategic Capital. The round also includes... |
| 13.10.2021 | Lark Health Raises $100M for Digital Care Management & Prevention Platform | What You Should Know:
– Lark Health, a healthcare technology company aimed at delivering infinitely scalable, virtual chronic and preventative healthcare through conversational AI announced it has raised $100M in Series D funding led by Dee... |
| 04.08.2021 | Deerfield : Announces New $1.4-billion Private Investment Fund | Deerfield Management Company, a New York City-based healthcare investment firm focused on advancing healthcare through investment, information and philanthropy, today announced that it has launched Deerfield Private Design Fund V, L.P. The ... |
| 29.06.2021 | Blue Cross and Blue Shield Association : NC Invests in Providing Services and Solutions to Independent Physicians, Offering an Alternative Path to Sustainable Practice Growth | 29 Jun 2021 Blue Cross NC Invests in Providing Services and Solutions to Independent Physicians, Offering an Alternative Path to Sustainable Practice Growth
New services to support growth of independent physician practices
DURHAM, N.C. - Br... |
| 28.06.2021 | Novocardia™ Announces $53.7 Million Financing Led by Deerfield Management | |
| 06.04.2021 | 'Unsurprising' but 'deeply disappointing': Deerfield report finds vast gender gap in VC-backed healthcare | Studies on diversity in the life sciences industry often look at the makeup of companies’ employees, executive teams and board members. In a new report, Deerfield Management zeroed in on early-stage companies and the venture capital firms t... |
| 02.03.2021 | Meet the top 8 VC firms that placed the most bets on startups changing how doctors get paid and building the future of medicine | Iyah Romm, Cityblock's CEO, and Toyin Ajayi, the chief health officer. Cityblock Health This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Redeem now
Healthcare startups trying to change the... |
| 09.02.2021 | Pairwise raises $90m to sell nutrient-dense gene-edited salad leaf | Apples that don’t brown. Lettuce that never wilts. Strawberries that burst with flavor.
Gene editing, it is hoped, could turn all of these appealing notions into realities.
Durham, North Carolina-based Pairwise is aiming to be among the fir... |
| 03.08.2020 | Baird Capital Portfolio Company ReMed Acquires Learning Services | CHICAGO – August 3, 2020 –Baird Capital, the direct private investment arm of Baird, announced today that its portfolio company ReMed had acquired Learning Services Corp. (Learning Services). The two industry leaders in brain injury rehabil... |
| 29.07.2020 | BlackRock Leads Sema4’s $121M Series C | 21 Shares Email Facebook Twitter LinkedIn
Patient-centered health intelligence company Sema4 saw its post-money valuation go above $1 billion after closing an oversubscribed $121 million Series C financing round, the company announced Wedne... |
| 23.06.2020 | Somatus Lands $64M to Expand Value-Based Kidney Care Model | What You Should Know:
– Somatus raises $64M in Series C funding led by Longitudinal Capital to fuel the expansion of its value-based kidney care model.
– Somatus will use the funding to continue to scale its model nationally and invest in t... |
| 24.05.2020 | The Sunday Briefing | #103 | The Vancouver Tech Journal brings you news, insight, opinions, and the lesser-known stories from Vancouver's innovation ecosystem. This is The Sunday Briefing. Enjoy.
My latest piece of writing is a profile of Rich Osborn, the managing part... |
| 22.05.2020 | Nuclear medicine startup ARTMS Products raises $26.4 million CAD Series A | Vancouver-based startup ARTMS Products, which produces medical isotopes, has raised a $26.4 million CAD ($19 million USD) Series A funding round. This round brings the company’s total funding to more than $30 million CAD ($26 million USD).
... |
| 08.04.2020 | Deerfield raises $840m fund targeting cutting-edge drug, medtech development | Deerfield Management Company has hit an $840m final close for its second Healthcare Innovations fund, which will target |
| 07.04.2020 | Deerfield closes $840M Healthcare Venture Fund II to invest in advancements in science for promising therapeutics | Deerfield, a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy, today announced the closing of $840 million in Deerfield Healthcare Innovations Fund ll, which will inves... |
| 07.04.2020 | Deerfield pulls off $840M healthcare venture fund—the 4th in a week | Join the club, Deerfield. The investment management firm raised $840 million for its second healthcare-focused fund, joining Arch Venture Partners, Flagship Pioneering and venBio Partners, all of which announced new funds last week.
The fun... |
| 06.04.2020 | Deerfield pulls off $840M healthcare venture fund—the 4th in a week
W h i t e p a p e r
Weighing the Costs: | Join the club, Deerfield. The investment management firm raised $840 million for its second healthcare-focused fund, joining Arch Venture Partners, Flagship Pioneering and venBio Partners, all of which announced new funds last week.
Sponsor... |
| 06.04.2020 | Deerfield Closes $840M Healthcare Venture Fund | NEW YORK--(BUSINESS WIRE)--Deerfield Management Company, L.P. today announced the closing of the Deerfield Healthcare Innovations Fund ll, L.P., which will invest in advancements in science that may lead to important therapeutic interventio... |
| 06.04.2020 | Deerfield Completes Healthcare Venture Fund, at $840M | NYC-based Investment firm Deerfield Management Company, L.P. closed the Deerfield Healthcare Innovations Fund ll, L.P., at $840m.
The Healthcare Innovations Fund II will invest in advancements in science that may lead to important therapeut... |
| 05.03.2020 | Element Science Nabs $145.6M to Commercialize Wearable Cardioverter Defibrillator | What You Need to Know:
– Element Science raises $145.6M in Series C funding to led by Deerfield Healthcare and Qiming Venture Partners USA, includes Cormorant Asset Management and Invus Opportunities.
– Funding will enable Element Science t... |
| 20.02.2020 | The evolution of New York City as a bioinnovation hub highlighted in new report | Three years ago, in its inaugural report on the venture capital landscape, New York City Health Business Leaders calculated that 79 startups and growth stage companies received $703 million in 2017. To put that in a national perspective, St... |
| 02.01.2020 | Deerfield Management and Duke University Launch Four Points Innovation | Duke University and Deerfield Management Company, a healthcare investment firm, have launched Four Points Innovation, a major translational research collaboration effort.
Spearheaded by Duke University’s Office of Licensing & Ventures (... |
| 14.10.2019 | Top 10 VCs investing in medical device companies | They include NEA, Versant Ventures, SOSV and Innova Memphis
Healthtech is a big and broad space, so much so that there are whole subsectors that see more investments than entire industries.
Medical device companies, for example, raised $2.9... |
| 17.09.2019 | Boulder’s Edgewise Therapeutics closes $50 million Series B financing | Edgewise Therapeutics, a Boulder company working to develop new therapies for treating patients with debilitating musculoskeletal disease, announced the closing of a $50 million Series B financing round on Tuesday.
The funding will help the... |
| 05.10.2018 | Tris Pharma Receives $125M Debt Financing from Deerfield | Deerfield provided $125m to refinance existing debt and provide growth capital to Tris Pharma, Inc., a Monmouth Junction, NJ-based fully integrated pharmaceutical company.
The company intends to use the funds to expand its branded pharmaceu... |
| 26.06.2018 | The Biggest Wisconsin Venture Round of the Decade… Didn’t Happen | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Details surrounding a $127.4 million funding round, which groups that track venture capital investments have said Janesville, WI-based Shine Medical Technologies raised in 201... |
| 25.05.2018 | Pfizer, Merck Lead Strata Oncology’s $26M Series B Round | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
In what company leaders describe as a “huge step,” Ann Arbor, MI-based precision medicine startup Strata Oncology this week closed a $26 million Series B investment round led ... |
| 13.04.2018 | Sollis Therapeutics Receives up to $50m Investment from Deerfield Management | Sollis Therapeutics, a Columbus, Ohio-based clinical-stage biotechnology company, received an up to $50m investment.
The total equity financing was led by from Deerfield Management.
The company intends to use the funds for the development o... |
| 12.04.2018 | Deerfield Leads Investment of up to $50 Million in Sollis Therapeutics' Innovative Solution for Sciatica Pain | Deerfield Management and Sollis Therapeutics today announced a Deerfield-led investment of up to $50 million in Sollis Therapeutics. The investment will support the development of an innovative non-opioid and non-steroid solution for pain a... |
| 23.03.2018 | Dracen Pharmaceuticals Raises $40M in Series A Funding | Dracen Pharmaceuticals, Inc., a Baltimore, Maryland, United States-based private company developing proprietary anti-cancer drugs discovered at the Johns Hopkins University and the Institute of Organic Chemistry and Biochemistry of the Czec... |
| 22.03.2018 | Deerfield leads oncology startup Dracen Pharma’s $40M series A | Deerfield Management will put up $36 million of Dracen Pharma’s $40 million series A round. The funds will propel the startup’s cancer programs into clinical trials.
The Baltimore-based company came to life in 2017 and is working on cancer ... |
| 20.03.2018 | Monsanto Invests in $25m Series A for Pairwise after Cofounding CRISPR Startup | Pairwise Plants has raised a $25 million Series A round co-led by Monsanto Growth Ventures and healthcare investment firm Deerfield Management.
Pairwise is a gene-editing company that has licensed programmable base editing technology from H... |
| 26.10.2017 | Phoenix Pulls in $12M to Fuel Growth of Neutron Generators | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Things are accelerating at Phoenix.
The Monona, WI-based business, which manufactures particle accelerator-based neutron generators and other machines, has outgrown its curren... |
| 26.10.2017 | Phoenix Raises $12M in Growth Funding | Phoenix (FKA Phoenix Nuclear Labs), a Monana, Wis.-based developer of nuclear technology, closed on $12M in funding.
The round was led by New York-based Deerfield Management Company with participation from several Wisconsin-based investment... |
| 06.02.2017 | Deerfield Leads $22.6M Series A for Chondrial Therapeutics | Chondrial Therapeutics, Inc., an emerging biotechnology company focused on the treatment of rare mitochondrial diseases, announced today that it has secured up to $22.6 million in Series A financing led by Deerfield Management and has appoi... |
| 06.02.2017 | Chondrial Therapeutics Raises $22.6 Million | Chondrial Therapeutics, Inc., an emerging biotechnology company focused on the treatment of rare mitochondrial diseases, announced today that it has secured up to $22.6 million in Series A financing led by Deerfield Management and has appoi... |
| 28.11.2016 | Deerfield close to hitting Fund IV goal after raising $2.4bn | Deerfield Management Company has raised about $2.4bn for its fourth fund, which looks to provide flexible private financ |
| 16.06.2016 | Blade Therapeutics Raises $45M Series B Led by Deerfield Management | Deerfield Management Company today announced its lead investment in the visionary anti-fibrotic company Blade Therapeutics. Blade Therapeutics is developing cutting edge therapies to treat patients with diverse fibrotic diseases for which t... |
| 27.01.2016 | Aprecia Pharmaceuticals Raised $35M in Funding | Aprecia Pharmaceuticals, a Blue Ash, Ohio-based specialty pharmaceutical company using its proprietary 3D printing technology platform to develop and manufacture pharmaceuticals, raised $35m in funding.
The round was led by Deerfield Manage... |
| 17.12.2015 | Hallux Completes $7.1M Series A Financing | Hallux Incorporated, a Laguna Hills, Calif.-based investigational-stage pharmaceutical company focused on developing a new dosage form and route of administration for treating onychomycosis, completed a $7.1m Series A financing.
The round w... |
| 14.12.2015 | Hallux tackles toenail fungus with $7M from Deerfield | “We feel we have the expertise and intellectual property to improve upon what that company had done,” Taylor said, though he won’t indicate which company Hallux acquired the technology from.
One of the most effective therapies for toenail f... |
| 16.09.2015 | Epion Health raises follow-on funding to scale business for new provider customers | Epion Health provides customized intake forms for providers. In addition to asking questions about medical history and the medication patients take, the software-as-a-service tool for mobile devices also provides targeted content. When pati... |
| 10.08.2015 | Editas Medicine Raises $20M in Venture Capital Funding | Editas Medicine, a Cambridge, MA-based developer of genome-editing technology, raised $20m in venture capital funding.
Backers included Deerfield Management Company, L.P.‘s Deerfield Healthcare Innovations Fund, L.P., and Deerfield Private ... |
| 10.08.2015 | Genome editing company Editas gets infused with $120M | Investors in the company include Google Ventures, Khosla Ventures and Bill Gates
We like to complain about the world a lot, but this really is such a cool time to be alive. We are coming up with amazing technology at a more rapid pace than ... |
| 10.08.2015 | Daily funding roundup - August 10, 2015 | Editas Medicine Inc secured $120M; Turing Pharmaceuticals bagged $90M; Vainglory raised $26M
Editas Medicine Inc. raised $120 million from investors to support development of a technology that can precisely edit DNA and potentially treat fa... |
| 29.07.2015 | Deerfield Management’s Jim Flynn on CRISPR, and that $550M new fund | The venture firm’s been around since 1994, and has about $7 billion in assets. It invests pretty consistently across the healthcare board – in biotech, medical device, health services and healthcare IT.
It’s a 12-year fund, though Flynn exp... |
| 29.07.2015 | Deerfield closes healthcare venture fund on $550m | Healthcare-focused investment firm Deerfield Management Company has held a $550m final close for its healthcare innovati |
| 28.07.2015 | Deerfield Management launches $550M biotech fund, has impressive investor base and will turn some profits over to charity | Deerfield, around since 1994, manages more than $5 billion in funds – all in companies related to healthcare.
The dollars from this fund, which is quite large in terms of healthcare-focused funds, will donate the profits that aren’t allocat... |
| 28.07.2015 | Daily funding roundup - July 28, 2015 | Deliveroo took $70M; Kareo pulled in $55M; MacroFab closed $2M
Deliveroo, a food delivery startup based in the United Kingdom, took a $70 million round, according to a report from VentureBeat. The round was led by Greenoaks Capital and Inde... |
| 28.07.2015 | Deerfield Closes Healthcare Venture-Capital Fund at $550M | New York City-based investment firm Deerfield Management Company, L.P., closed its latest fund at $550 million.
Deerfield Healthcare Innovations Fund, L.P., will focus on investing in advancements in science that may lead to therapeutic int... |
| 09.06.2015 | NeoChord Secures $20 Million Series C Financing | Eden Prairie, Minn., June 9 2015 – NeoChord, a medical technology company, announced today it has closed an oversubscribed $20 million Series C financing round led by Deerfield Management, with participation from Baird Capital's Venture Cap... |
| 09.01.2015 | AveXis Raises $10M in Funding | AveXis, a Dallas, Texas-based gene therapy-focused biotech company, raised $10m in funding.
The round was led by Deerfield Management and Roche Venture Fund. In conjunction with the funding, Jonathan Leff of Deerfield and Carole Nuechterlei... |
| 02.12.2014 | Conventus Orthopaedics Raises $24M |
MINNEAPOLIS, MN, Global medical device company dedicated to revolutionizing fracture treatment, today announced the completion of a $24 million Series AA equity round of funding.
>> Click here for more funding data on Conventus Ort... |
| 18.07.2014 | Multitasking in the waiting room: Epion Health raises $4.5M to support provider rollout | Epion Health will use the funding to boost its sales and operations team after athenahealth agreed to make its content tool available to its network of 52,000 providers.
In the past couple of years since it won Startupalooza NJ, Epion has s... |
| 16.05.2014 | Proteon Therapeutics Raises $45M in Series D Equity Financing | Proteon Therapeutics Inc., a Waltham, Mass.-based biopharmaceutical company developing pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases, raised $45m in Series D equity financing.
This inclu... |
| 13.04.2014 | OMNIlife science Closes $27.5M Debt Financing | OMNIlife science, Inc., an East Taunton, MA-based medical technology company, closed a $27.5m debt financing.
The debt facility is being provided by affiliates of Deerfield Management Company.
The company plans to use the proceeds to contin... |
| 08.04.2014 | Deerfield raises $1.6B healthcare fund | Deerfield Management Co. said it raised a fund aimed at healthcare investments that’s worth $1.6 billion.
Deerfield Private Design Fund III is "designed to provide flexible private financing to healthcare companies," according to ... |
| 08.04.2014 | Deerfield secures $1.6bn for third fund | Healthcare-focused investment firm Deerfield Management Company has secured $1.6bn for its third fund. With the new fund |
| 03.04.2014 | Deerfield Management launches $1.6bn fund | Healthcare-focused investment firm Deerfield Management Company is seeking $1.6bn for its new private equity fund, AltAs |
| 03.04.2013 | WorldOne Secures $35M from Deerfield | WorldOne, a New York-based provider of healthcare data collection, insights and intelligence solutions, secured $35m in funding commitments from Deerfield Management Company.
The company intends to use the funds to accelerate the developmen... |
| - | Multitasking in the waiting room: Epion Health raises $4.5M to support provider rollout | A health IT company has closed a $4.5 million Series A round to support the expansion of its digital intake platform that also includes a patient check-in tool across athenahealth’s providers. The move comes after Epion Health participated ... |
| - | Epion Health raises follow-on funding to scale business for new provider customers | A digital health company that developed an automated intake system for providers recently secured follow-on funding from Deerfield. The growth capital will help Epion Health expand its team of employees to support new enterprise-level accou... |
| - | Deerfield Management launches $550M biotech fund, has impressive investor base and will turn some profits over to charity | Deerfield Management is kicking off a $550 million biotech venture fund – and has an impressive and unconventional slew of backers for a partnership that will direct all profits toward charitable purposes.
Investors include New York-Presbyt... |
| - | Pleno Secures $40M to Disrupt Sequencing Market, Scale Multi-omics | What You Should Know:
Pleno was founded by Pieter van Rooyen, a well-known biotech engineer who built and sold his last company, Edico Genome, to Illumina for $100 million. Edico’s Dragen technology has become a staple in genetics research.... |
| - | Deerfield Management’s Jim Flynn on CRISPR, and that $550M new fund | Deerfield Management recently announced a new, $550 million healthcare fund that’ll direct its profits to charity – certainly an unconventional, and marketable, route for a large venture capital firm.
I spoke with Jim Flynn, the firm’s pres... |
| - | The evolution of New York City as a bioinnovation hub highlighted in new report | Three years ago, in its inaugural report on the venture capital landscape, New York City Health Business Leaders calculated that 79 startups and growth stage companies received $703 million in 2017. To put that in a national perspective, St... |
| - | PQ Bypass Sold to Endologix | Dublin, Ireland. 14 April 2021. Seroba’s portfolio company, PQ Bypass Inc., a medical device pioneer advancing the treatment of complex peripheral artery disease (PAD), has been acquired by Endologix, a global medical device company wholly ... |
| - | Hallux tackles toenail fungus with $7M from Deerfield | Stealth Los Angeles-area startup Hallux is building a newfangled drug-delivery combo to treat toenail fungus: It’s in early clinical trials for its micro-insert that delivers a high dose of a powerful antifungal drug directly to the toenail... |
| - | InCarda Therapeutics Provides Corporate Update Highlighting Fundraising and Clinical Development Milestones | Oversubscribed $42 Million Series B Financing Provides Significant Runway to Support Continued Advancement of Innovative Inhaled Cardiovascular Therapy
First Patients Dosed in Phase 2 Clinical Trial of First-of-its-Kind Inhaled Antiarrhyth... |
